These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 2718235)
21. Plasma exchange versus an affinity column for cholesterol reduction. Burgstaler EA; Pineda AA J Clin Apher; 1992; 7(2):69-74. PubMed ID: 1429490 [TBL] [Abstract][Full Text] [Related]
22. The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy. Yamamoto A; Harada-Shiba M; Kawaguchi A; Oi K; Kubo H; Sakai S; Mikami Y; Imai T; Ito T; Kato H; Endo M; Sato I; Suzuki Y; Hori H Atherosclerosis; 2000 Nov; 153(1):89-98. PubMed ID: 11058703 [TBL] [Abstract][Full Text] [Related]
23. Long term result of LDL selective plasma adsorption therapy on familial hypercholesterolemia. Odaka M; Kobayashi H; Tabata Y; Soeda K; Hayashi H; Ito S; Murotani N; Saito Y; Nishide T; Shinomiya M Biomater Artif Cells Artif Organs; 1987; 15(1):113-24. PubMed ID: 3449131 [TBL] [Abstract][Full Text] [Related]
24. Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia. Napoli C; Ambrosio G; Scarpato N; Corso G; Palumbo G; D'Armiento FP; Mancini FP; Malorni A; Formisano S; Ruocco A; Calí A; Chiariello M Am Heart J; 1997 May; 133(5):585-95. PubMed ID: 9141382 [TBL] [Abstract][Full Text] [Related]
25. Role of LDL apheresis in a case of homozygous familial hypercholesterolemia. Naveen T; Biswas A; Wig N; Soneja M; Jorwal P; Durga CS; Singla P; Chaudhary C; Baitha U Drug Discov Ther; 2019; 13(1):59-61. PubMed ID: 30880324 [TBL] [Abstract][Full Text] [Related]
26. Lipids and lipoprotein changes after heart and liver transplantation in a patient with homozygous familial hypercholesterolemia. Valdivielso P; Escolar JL; Cuervas-Mons V; Pulpón LA; Chaparro MA; González-Santos P Ann Intern Med; 1988 Feb; 108(2):204-6. PubMed ID: 3277507 [TBL] [Abstract][Full Text] [Related]
27. LDL-apheresis: results of longterm treatment and vascular outcome. Keller C Atherosclerosis; 1991 Jan; 86(1):1-8. PubMed ID: 2064631 [TBL] [Abstract][Full Text] [Related]
28. Plasmapheresis in familial hypercholesterolemia. Thompson GR; Barbir M; Okabayashi K; Trayner I; Larkin S Arteriosclerosis; 1989; 9(1 Suppl):I152-7. PubMed ID: 2912429 [TBL] [Abstract][Full Text] [Related]
29. Effect of plasma exchange with and without concomitant drug treatment on lipids and lipoproteins in patients with familial hypercholesterolemia confirmed by tissue culture. Keller C; Hailer S; Demant T; Wolfram G; Zöllner N Atherosclerosis; 1985 Nov; 57(2-3):225-34. PubMed ID: 4084356 [TBL] [Abstract][Full Text] [Related]
30. Disease control via intensified lipoprotein apheresis in three siblings with familial hypercholesterolemia. Taylan C; Schlune A; Meissner T; Ažukaitis K; Udink Ten Cate FE; Weber LT J Clin Lipidol; 2016; 10(6):1303-1310. PubMed ID: 27919346 [TBL] [Abstract][Full Text] [Related]
31. Reduction of Lp(a) by different methods of plasma exchange. Schenck I; Keller C; Hailer S; Wolfram G; Zöllner N Klin Wochenschr; 1988 Dec; 66(24):1197-201. PubMed ID: 2976858 [TBL] [Abstract][Full Text] [Related]
33. Treatment of homozygous familial hypercholesterolemia by plasma exchange and LDL-apheresis. Palcoux JB; Meyer M; Jouanel P; Tridon A; Vanlieferinghen P; Carla H; Malpuech G Transfus Sci; 1993 Oct; 14(4):423-7. PubMed ID: 10146648 [TBL] [Abstract][Full Text] [Related]
34. LDL cholesterol apheresis by dextran sulfate cellulose adsorption. Long-term experience in patients with familial hypercholesterolemia. Olbricht CJ; Schulzeck P ASAIO Trans; 1991; 37(3):M492-3. PubMed ID: 1751248 [TBL] [Abstract][Full Text] [Related]
35. From plasma-exchange to LDL-apheresis: new developments in the treatment of familial hypercholesterolemia. Postiglione A; Gnasso A; Mastranzo P; Montefusco S; Motti C; Gallotta G; Cortese C; Scarpato N Beitr Infusionsther; 1988; 23():74-80. PubMed ID: 2484784 [No Abstract] [Full Text] [Related]
36. The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia. Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P Circulation; 2017 Aug; 136(9):880-882. PubMed ID: 28847800 [No Abstract] [Full Text] [Related]
37. Impact of evolocumab treatment on low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemic patients withdrawing from regular apheresis. Kawashiri MA; Nohara A; Higashikata T; Tada H; Nakanishi C; Okada H; Konno T; Sakata K; Hayashi K; Inazu A; Mabuchi H; Yamagishi M Atherosclerosis; 2017 Oct; 265():225-230. PubMed ID: 28926730 [TBL] [Abstract][Full Text] [Related]
38. Comparison of two low-density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia. Drouin-Chartier JP; Tremblay AJ; Bergeron J; Pelletier M; Laflamme N; Lamarche B; Couture P J Clin Apher; 2016 Aug; 31(4):359-67. PubMed ID: 26011648 [TBL] [Abstract][Full Text] [Related]
39. The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy. Yamamoto A; Harada-Shiba M; Endo M; Kusakabe N; Tanioka T; Kato H; Shoji T Atherosclerosis; 2006 May; 186(1):126-31. PubMed ID: 16043185 [TBL] [Abstract][Full Text] [Related]
40. Low-density lipoprotein apheresis by membrane differential filtration (cascade filtration) via arteriovenous fistula performed in children with familial hypercholesterolemia. Gülle S; Bak M; Serdaroglu E; Can D; Karabay O Ther Apher Dial; 2010 Feb; 14(1):87-92. PubMed ID: 20438523 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]